Tuesday, May 5, 2015
U.S. clinics avoiding government oversight of "stem cell" treatments
Federal Regulatory Oversight of US Clinics Marketing Adipose-Derived Autologous Stem Cell Interventions: Insights From 3 New FDA Draft Guidance Documents. Leigh G. Turner, PhD, Mayo Clinic Proceedings, Volume 90, Issue 5, May 2015, Pages 567–571
